These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 25038912)

  • 1. Polymorphism of DNA repair gene xrcc1 and lung cancer risk.
    Wang H; Liu Z
    Cell Biochem Biophys; 2014 Dec; 70(3):1881-6. PubMed ID: 25038912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA repair gene X-ray repair cross complementing group 1 Arg194Trp polymorphism on the risk of lung cancer: a meta-analysis on 22 studies.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z; Zhan Q; Lin H
    J Thorac Oncol; 2010 Nov; 5(11):1741-7. PubMed ID: 20975374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis.
    Zheng H; Wang Z; Shi X; Wang Z
    Lung Cancer; 2009 Sep; 65(3):268-73. PubMed ID: 19329222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
    Dong LM; Zhang XY; Teng H; Li MS; Wang P
    Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.
    Liu G; Zhou W; Park S; Wang LI; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer; 2004 Dec; 101(12):2802-8. PubMed ID: 15534883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
    Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assoication of XRCC1 gene polymorphisms with risk of non-small cell lung cancer.
    Kang S; Ma Y; Liu C; Cao C; Hanbateer ; Qi J; Li J; Wu X
    Int J Clin Exp Pathol; 2015; 8(4):4171-6. PubMed ID: 26097609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis.
    Wang Y; Yang H; Li H; Li L; Wang H; Liu C; Zheng Y
    Cancer Lett; 2009 Nov; 285(2):134-40. PubMed ID: 19481337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XRCC1 polymorphism and lung cancer risk.
    Schneider J; Classen V; Helmig S
    Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
    Park JY; Lee SY; Jeon HS; Bae NC; Chae SC; Joo S; Kim CH; Park JH; Kam S; Kim IS; Jung TH
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):23-7. PubMed ID: 11815397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis.
    Wang C; Sun Y; Han R
    Urology; 2008 Oct; 72(4):869-72. PubMed ID: 18336890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies.
    Dai L; Duan F; Wang P; Song C; Wang K; Zhang J
    Mol Biol Rep; 2012 Oct; 39(10):9535-47. PubMed ID: 22729882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the DNA repair gene XRCC1 and breast cancer.
    Duell EJ; Millikan RC; Pittman GS; Winkel S; Lunn RM; Tse CK; Eaton A; Mohrenweiser HW; Newman B; Bell DA
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):217-22. PubMed ID: 11303590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies.
    Hu Z; Ma H; Chen F; Wei Q; Shen H
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1810-8. PubMed ID: 16030121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association and multiple interaction analysis among five XRCC1 polymorphic variants in modulating lung cancer risk in North Indian population.
    Singh A; Singh N; Behera D; Sharma S
    DNA Repair (Amst); 2016 Nov; 47():30-41. PubMed ID: 27707541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.
    Stern MC; Siegmund KD; Corral R; Haile RW
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):609-15. PubMed ID: 15767338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The polymorphisms of XRCC1 gene and susceptibility to pulmonary cancer].
    Wang N; Wu YJ; Zhou XL; Wu YM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Jan; 30(1):41-4. PubMed ID: 22730687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
    Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
    Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.